Clinical and laboratory epidemiological monitoring of pregnant women with evaluation of the obstetric, foetal and neonatal risk associated with SARS-CoV-2 during the COVID-19 pandemic– COroFET FRESH-PEF73499-en CHARLOTTE DUBUCS Clinical and laboratory epidemiological monitoring of pregnant women with evaluation of the obstetric, foetal and neonatal risk associated with SARS-CoV-2 during the COVID-19 pandemic– COroFET COroFET FRESH-PEF73499-en 73499 FRESH-PEF73499 Charlotte DUBUCS CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (CHUT) Epidemiology France Portal (PEF) null Charlotte;DUBUCS Gynaecology and obstetrics Infectious disease medicine COVID-19 In this situation in which data are crucial to understanding the effects of SARS-CoV-2 in the pregnant female population, our primary objective is to collect clinical and paraclinical data from a large sample of women recruited from our level 3 maternity unit, and to create biological and tissue collections with a view to responding to a series of questions, partly explained in the research programme, but which may also evolve as knowledge progresses. null France Occitanie Individuals General population Female Young Adult (19 to 24 years) Adult (25 to 44 years) Adult females aged 18 years or over at the date of inclusion Pregnant women giving birth at the Paule de Viguier maternity unit, Toulouse University Hospital, in the study, between April 2020 and April 2021, regardless of pregnancy outcome (live births, intrauterine foetal death, termination of pregnancy, i.e. miscarriages, medical termination of pregnancy) and term Women having given their consent to take part in the study Women registered with a social security scheme (including the state welfare scheme) Clinical data Biological data Other [1000-10000[ individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study target 3,600 by end April 2021 Unknown To be defined